Format

Send to

Choose Destination
J Med Chem. 2008 Dec 25;51(24):7915-20. doi: 10.1021/jm801065q.

Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo.

Author information

1
Novartis Institutes for BioMedical Research, Forum 1, Novartis Campus, CH-4002 Basel, Switzerland. gebhard.thoma@novartis.com

Abstract

The interaction of the chemokine receptor CXCR4 with its ligand CXCL12 is involved in many biological processes such as hematopoesis, migration of immune cells, as well as in cancer metastasis. CXCR4 also mediates the infection of T-cells with X4-tropic HIV functioning as a coreceptor for the viral envelope protein gp120. Here, we describe highly potent, selective CXCR4 inhibitors that block CXCR4/CXCL12 interactions in vitro and in vivo as well as the infection of target cells by X4-tropic HIV.

PMID:
19053768
DOI:
10.1021/jm801065q
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center